Skip to main content

Postpartum Depression

Just over half of women in a study who experienced a major depressive episode during pregnancy received no mental health treatment for it, researchers reported in the journal Psychiatric Services.
The benefits of Sage Therapeutics Inc's experimental treatment for postpartum depression outweigh risks, an advisory panel to the U.S. Food and Drug Administration said.
ORLANDO, Fla.—Infusion with the investigational compound brexanolone outperformed selective serotonin reuptake inhibitors (SSRIs) for the treatment of postpartum depression, according to a study presented at Psych Congress 2018.
Women who have asthma during their pregnancies are more likely to experience postpartum depression after delivery, a large Canadian study suggests.
A 60-hour infusion of brexanolone significantly improves symptoms in women with postpartum depression, according to results from two phase 3 trials.
Back to Top